Mesa Laboratories Net Income
| MLAB Stock | USD 88.63 1.96 2.16% |
As of the 18th of February 2026, Mesa Laboratories secures the Risk Adjusted Performance of 0.0608, mean deviation of 1.97, and Downside Deviation of 2.45. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mesa Laboratories, as well as the relationship between them.
Mesa Laboratories Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.6357 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -1.8 M | -1.9 M | |
| Net Income Applicable To Common Shares | 1.1 M | 1 M | |
| Net Loss | -1.8 M | -1.9 M | |
| Net Loss | (0.42) | (0.44) | |
| Net Loss | (0.38) | (0.36) |
Mesa | Net Income | Build AI portfolio with Mesa Stock |
Analyzing Mesa Laboratories's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Mesa Laboratories's current valuation and future prospects.
Latest Mesa Laboratories' Net Income Growth Pattern
Below is the plot of the Net Income of Mesa Laboratories over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Mesa Laboratories financial statement analysis. It represents the amount of money remaining after all of Mesa Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Mesa Laboratories' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mesa Laboratories' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1.97 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Mesa Net Income Regression Statistics
| Arithmetic Mean | (11,181,355) | |
| Coefficient Of Variation | (561.94) | |
| Mean Deviation | 28,595,841 | |
| Median | 1,871,000 | |
| Standard Deviation | 62,832,102 | |
| Sample Variance | 3947.9T | |
| Range | 265.4M | |
| R-Value | (0.30) | |
| Mean Square Error | 3825.6T | |
| R-Squared | 0.09 | |
| Significance | 0.24 | |
| Slope | (3,764,585) | |
| Total Sum of Squares | 63166T |
Mesa Net Income History
Other Fundumenentals of Mesa Laboratories
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Mesa Laboratories Net Income component correlations
Mesa Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Mesa Laboratories is extremely important. It helps to project a fair market value of Mesa Stock properly, considering its historical fundamentals such as Net Income. Since Mesa Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mesa Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mesa Laboratories' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. Expected growth trajectory for Mesa significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Mesa Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.29) | Dividend Share 0.64 | Earnings Share 0.65 | Revenue Per Share | Quarterly Revenue Growth 0.036 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Mesa Laboratories' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mesa Laboratories represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Mesa Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Mesa Laboratories 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mesa Laboratories' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mesa Laboratories.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Mesa Laboratories on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Mesa Laboratories or generate 0.0% return on investment in Mesa Laboratories over 90 days. Mesa Laboratories is related to or competes with LightPath Technologies, Microvision, Vishay Precision, Gravity, Pubmatic, EGain, and GDEV. Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services ... More
Mesa Laboratories Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mesa Laboratories' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mesa Laboratories upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.45 | |||
| Information Ratio | 0.0494 | |||
| Maximum Drawdown | 16.68 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 4.57 |
Mesa Laboratories Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesa Laboratories' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mesa Laboratories' standard deviation. In reality, there are many statistical measures that can use Mesa Laboratories historical prices to predict the future Mesa Laboratories' volatility.| Risk Adjusted Performance | 0.0608 | |||
| Jensen Alpha | 0.1228 | |||
| Total Risk Alpha | 0.029 | |||
| Sortino Ratio | 0.0601 | |||
| Treynor Ratio | 0.1216 |
Mesa Laboratories February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0608 | |||
| Market Risk Adjusted Performance | 0.1316 | |||
| Mean Deviation | 1.97 | |||
| Semi Deviation | 2.2 | |||
| Downside Deviation | 2.45 | |||
| Coefficient Of Variation | 1486.96 | |||
| Standard Deviation | 2.97 | |||
| Variance | 8.85 | |||
| Information Ratio | 0.0494 | |||
| Jensen Alpha | 0.1228 | |||
| Total Risk Alpha | 0.029 | |||
| Sortino Ratio | 0.0601 | |||
| Treynor Ratio | 0.1216 | |||
| Maximum Drawdown | 16.68 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 4.57 | |||
| Downside Variance | 5.99 | |||
| Semi Variance | 4.84 | |||
| Expected Short fall | (2.36) | |||
| Skewness | 1.13 | |||
| Kurtosis | 3.19 |
Mesa Laboratories Backtested Returns
Mesa Laboratories appears to be very steady, given 3 months investment horizon. Mesa Laboratories has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Mesa Laboratories, which you can use to evaluate the volatility of the firm. Please exercise Mesa Laboratories' Downside Deviation of 2.45, risk adjusted performance of 0.0608, and Mean Deviation of 1.97 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Mesa Laboratories holds a performance score of 10. The company secures a Beta (Market Risk) of 1.56, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesa Laboratories will likely underperform. Please check Mesa Laboratories' treynor ratio, downside variance, kurtosis, as well as the relationship between the value at risk and expected short fall , to make a quick decision on whether Mesa Laboratories' current price movements will revert.
Auto-correlation | 0.07 |
Virtually no predictability
Mesa Laboratories has virtually no predictability. Overlapping area represents the amount of predictability between Mesa Laboratories time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mesa Laboratories price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Mesa Laboratories price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 17.71 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Mesa Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Mesa Laboratories reported net income of (1.97 Million). This is 100.37% lower than that of the Life Sciences Tools & Services sector and 101.53% lower than that of the Health Care industry. The net income for all United States stocks is 100.35% higher than that of the company.
Mesa Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mesa Laboratories' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mesa Laboratories could also be used in its relative valuation, which is a method of valuing Mesa Laboratories by comparing valuation metrics of similar companies.Mesa Laboratories is currently under evaluation in net income category among its peers.
Mesa Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mesa Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mesa Laboratories' managers, analysts, and investors.Environmental | Governance | Social |
Mesa Laboratories Institutional Holders
Institutional Holdings refers to the ownership stake in Mesa Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Mesa Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mesa Laboratories' value.| Shares | Hhg Plc | 2025-06-30 | 113.3 K | Select Equity Group Lp | 2025-06-30 | 102.2 K | Northern Trust Corp | 2025-06-30 | 92.7 K | Kennedy Capital Management Inc | 2025-06-30 | 90.5 K | Acadian Asset Management Llc | 2025-06-30 | 79.5 K | Ameriprise Financial Inc | 2025-06-30 | 73.5 K | Renaissance Technologies Corp | 2025-06-30 | 68 K | Bank Of America Corp | 2025-06-30 | 64.9 K | Charles Schwab Investment Management Inc | 2025-06-30 | 61.8 K | Blackrock Inc | 2025-06-30 | 791.1 K | Conestoga Capital Advisors, Llc | 2025-06-30 | 566.1 K |
Mesa Fundamentals
| Return On Equity | 0.0218 | ||||
| Return On Asset | 0.0247 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 652.5 M | ||||
| Shares Outstanding | 5.52 M | ||||
| Shares Owned By Insiders | 5.43 % | ||||
| Shares Owned By Institutions | 84.55 % | ||||
| Number Of Shares Shorted | 223.1 K | ||||
| Price To Earning | 433.94 X | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 2.02 X | ||||
| Revenue | 240.98 M | ||||
| Gross Profit | 154.48 M | ||||
| EBITDA | 42.35 M | ||||
| Net Income | (1.97 M) | ||||
| Cash And Equivalents | 43.75 M | ||||
| Cash Per Share | 8.23 X | ||||
| Total Debt | 181.47 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.90 X | ||||
| Book Value Per Share | 33.79 X | ||||
| Cash Flow From Operations | 46.81 M | ||||
| Short Ratio | 2.29 X | ||||
| Earnings Per Share | 0.65 X | ||||
| Target Price | 104.5 | ||||
| Number Of Employees | 730 | ||||
| Beta | 0.89 | ||||
| Market Capitalization | 500.49 M | ||||
| Total Asset | 433.35 M | ||||
| Retained Earnings | (188.94 M) | ||||
| Working Capital | (61.28 M) | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 657 K | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.29 % | ||||
| Net Asset | 433.35 M | ||||
| Last Dividend Paid | 0.64 |
About Mesa Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mesa Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mesa Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mesa Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. Expected growth trajectory for Mesa significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Mesa Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.29) | Dividend Share 0.64 | Earnings Share 0.65 | Revenue Per Share | Quarterly Revenue Growth 0.036 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Mesa Laboratories' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mesa Laboratories represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Mesa Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.